Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials

Author： Siegel Matthew Garber Mitchell Spencer Andrew Botwick Wendy Kumar Pawan Williams Robert Kozuka Kenji Shreeniwas Revati Pratha Vijaya Adelman Daniel

Publisher： Springer Publishing Company

ISSN： 0163-2116

Source： Digestive Diseases and Sciences, Vol.57, Iss.2, 2012-02, pp. : 440-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of single-dose mizoribine for patients with rheumatoid arthritis: results at 6 months after switching from a multiple-dose regimen without a change in total daily dose

By Nishimura Keita

Modern Rheumatology, Vol. 21, Iss. 2, 2011-04 ,pp. : 158-163

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Tolerability of Almotriptan in Controlled Clinical Trials

European Neurology, Vol. 53, Iss. 1, 2005-05 ,pp. : 29-33

Karger

Access to resources Recommend Favorite

Infusion of Reconstituted High‐Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 8, 2015-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review

By Fleseriu Maria

Pituitary, Vol. 14, Iss. 2, 2011-06 ,pp. : 184-193

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study)

By Yamanaka Hisashi

Modern Rheumatology, Vol. 21, Iss. 2, 2011-04 ,pp. : 122-133

Springer Publishing Company

Access to resources Recommend Favorite